The Link Between Bacterial Inflammagens, Leaky Gut Syndrome and Colorectal Cancer

Area of Science:

• Oncology
• Microbiology
• Immunology

Background:

• Colorectal cancer (CRC) is linked to chronic inflammation, infections, and altered inflammatory markers.
• Systemic inflammation is associated with abnormal blood clot formation and coagulopathies.
• Gut dysbiosis in CRC correlates with an inflammatory profile.

Purpose of the Study:

• To review the connection between gut dysbiosis, bacterial translocation, and circulating inflammagens in CRC.
• To explore the role of bacterial components like lipopolysaccharide (LPS) and lipoteichoic acid (LTA) in CRC pathogenesis.
• To highlight potential diagnostic and therapeutic targets related to bacterial inflammagens and coagulation.

Main Methods:

• Literature review of studies investigating gut microbiota, inflammation, coagulation, and colorectal carcinogenesis.
• Analysis of evidence linking bacterial products to systemic inflammation and hypercoagulation in CRC.
• Synthesis of findings on the contribution of bacterial inflammagens to colorectal cancer development.

Main Results:

• Gut dysbiosis facilitates bacterial entry into circulation, exposing the body to potent inflammagens (LPS, LTA).
• These bacterial components are implicated as key drivers of inflammation and hypercoagulation in CRC.
• Evidence suggests bacterial inflammagens contribute significantly to colorectal carcinogenesis.

Conclusions:

• Bacterial inflammagens and dysbiosis play a crucial role in colorectal cancer development and associated hypercoagulation.
• Early detection of coagulation activation and bacterial components in circulation and tumors are potential biomarkers.
• Modulating the gut microbiota and targeting bacterial inflammagens represent promising therapeutic avenues for CRC.